175 results
S-8
EX-4.5
b3ndw0
22 Feb 24
Registration of securities for employees
5:50pm
S-8
EX-4.4
mmuzfu5
22 Feb 24
Registration of securities for employees
5:50pm
8-K
EX-99.2
3rkj7fajj 8dvsa6sazs
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
8-K
EX-99.1
smks540 awyeq9yh
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
11-K
093teu5tzn4x lpbr93
28 Jun 23
Annual report of employee stock purchases
5:00pm